Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Director comp.
Appointed director
CC transcript

HAEMONETICS CORP (HAE) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 4 Bryant Diane M (Director) has filed a Form 4 on HAEMONETICS CORP
Txns: Granted 2,226 shares @ $0
08/08/2023 4 Dockendorff Charles J (Director) has filed a Form 4 on HAEMONETICS CORP
Txns: Granted 2,226 shares @ $0
08/08/2023 4 Zane Ellen M (Director) has filed a Form 4 on HAEMONETICS CORP
Txns: Granted 2,226 shares @ $0
08/08/2023 4 Pomeroy Claire (Director) has filed a Form 4 on HAEMONETICS CORP
Txns: Granted 2,226 shares @ $0
08/08/2023 4 KROLL MARK W (Director) has filed a Form 4 on HAEMONETICS CORP
Txns: Granted 2,226 shares @ $0
08/08/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/08/2023 4 COYLE MICHAEL J (Director) has filed a Form 4 on HAEMONETICS CORP
Txns: Granted 2,226 shares @ $0
08/08/2023 4 ABERNATHY ROBERT E (Director) has filed a Form 4 on HAEMONETICS CORP
Txns: Granted 2,226 shares @ $0
07/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2023 4 Simon, Christopher (President & CEO) has filed a Form 4 on HAEMONETICS CORP
Txns: Paid exercise price by delivering 117,667 shares @ $84.84, valued at $10M
Exercised 196,746 options to buy @ $28.615, valued at $5.6M
06/09/2023 4 Strong Stewart W (President, Global Hospital) has filed a Form 4 on HAEMONETICS CORP
Txns: Paid exercise price by delivering 5,053 shares @ $88, valued at $444.7k
Sold 2,538 shares @ $88.04, valued at $223.4k
Exercised 4,483 options to buy @ $56.57, valued at $253.6k
Exercised 2,410 options to buy @ $57.6, valued at $138.8k
06/01/2023 4 Lingamneni Anila (EVP, Chief Technology Officer) has filed a Form 4 on HAEMONETICS CORP
Txns: Sold 2,304 shares @ $83.33, valued at $192k
05/19/2023 4 Basil Michelle L (EVP and General Counsel) has filed a Form 4 on HAEMONETICS CORP
Txns: Paid exercise price by delivering 3,541 shares @ $83.34, valued at $295.1k
05/19/2023 4 Lingamneni Anila (EVP, Chief Technology Officer) has filed a Form 4 on HAEMONETICS CORP
Txns: Paid exercise price by delivering 1,385 shares @ $83.34, valued at $115.4k
05/19/2023 4 Llorens Josep (EVP, Global Manufacturing) has filed a Form 4 on HAEMONETICS CORP
Txns: Paid exercise price by delivering 1,423 shares @ $83.34, valued at $118.6k
05/19/2023 4 Miller Laurie A. (SVP, Human Resources) has filed a Form 4 on HAEMONETICS CORP
Txns: Paid exercise price by delivering 90 shares @ $83.34, valued at $7.5k
05/19/2023 4 Simon, Christopher (President & CEO) has filed a Form 4 on HAEMONETICS CORP
Txns: Paid exercise price by delivering 3,839 shares @ $83.34, valued at $319.9k
05/19/2023 4 Strong Stewart W (President, Global Hospital) has filed a Form 4 on HAEMONETICS CORP
Txns: Paid exercise price by delivering 1,087 shares @ $83.34, valued at $90.6k
05/17/2023 4 Maunsell Farris Maryanne (VP, Chief Accounting Officer) has filed a Form 4 on HAEMONETICS CORP
Txns: Granted 630 shares @ $0
Granted 1,425 options to buy @ $89.16, valued at $127.1k
05/17/2023 4 Strong Stewart W (President, Global Hospital) has filed a Form 4 on HAEMONETICS CORP
Txns: Granted 2,803 shares @ $0
Paid exercise price by delivering 250 shares @ $89.21, valued at $22.3k
Granted 6,335 options to buy @ $89.16, valued at $564.8k
05/17/2023 4 Miller Laurie A. (SVP, Human Resources) has filed a Form 4 on HAEMONETICS CORP
Txns: Granted 2,102 shares @ $0
Paid exercise price by delivering 235 shares @ $89.21, valued at $21k
Granted 4,751 options to buy @ $89.16, valued at $423.6k
05/17/2023 4 Lingamneni Anila (EVP, Chief Technology Officer) has filed a Form 4 on HAEMONETICS CORP
Txns: Granted 3,364 shares @ $0
Paid exercise price by delivering 318 shares @ $89.21, valued at $28.4k
Granted 7,602 options to buy @ $89.16, valued at $677.8k
05/17/2023 4 Llorens Josep (EVP, Global Manufacturing) has filed a Form 4 on HAEMONETICS CORP
Txns: Granted 3,084 shares @ $0
Paid exercise price by delivering 319 shares @ $89.21, valued at $28.5k
Granted 6,968 options to buy @ $89.16, valued at $621.3k
05/17/2023 4 Galvin Roy (President, Global Plasma & BC) has filed a Form 4 on HAEMONETICS CORP
Txns: Granted 2,243 shares @ $0
Granted 5,068 options to buy @ $89.16, valued at $451.9k
05/17/2023 4 Basil Michelle L (EVP and General Counsel) has filed a Form 4 on HAEMONETICS CORP
Txns: Granted 4,205 shares @ $0
Paid exercise price by delivering 446 shares @ $89.21, valued at $39.8k
Granted 9,502 options to buy @ $89.16, valued at $847.2k
05/17/2023 4 DArecca James (EVP, CFO) has filed a Form 4 on HAEMONETICS CORP
Txns: Granted 4,205 shares @ $0
Paid exercise price by delivering 349 shares @ $89.21, valued at $31.1k
Granted 9,502 options to buy @ $89.16, valued at $847.2k
05/17/2023 4 Simon, Christopher (President & CEO) has filed a Form 4 on HAEMONETICS CORP
Txns: Granted 18,225 shares @ $0
Paid exercise price by delivering 1,586 shares @ $89.21, valued at $141.5k
Granted 41,177 options to buy @ $89.16, valued at $3.7M
05/16/2023 4 Basil Michelle L (EVP and General Counsel) has filed a Form 4 on HAEMONETICS CORP
Txns: Paid exercise price by delivering 204 shares @ $88.16, valued at $18k
05/16/2023 4 Llorens Josep (EVP, Global Manufacturing) has filed a Form 4 on HAEMONETICS CORP
Txns: Paid exercise price by delivering 113 shares @ $88.16, valued at $10k
05/16/2023 4 Simon, Christopher (President & CEO) has filed a Form 4 on HAEMONETICS CORP
Txns: Paid exercise price by delivering 854 shares @ $88.16, valued at $75.3k
05/16/2023 4 Miller Laurie A. (SVP, Human Resources) has filed a Form 4 on HAEMONETICS CORP
Txns: Paid exercise price by delivering 32 shares @ $88.16, valued at $2.8k
05/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/25/2023 4 Llorens Josep (EVP, Global Manufacturing) has filed a Form 4 on HAEMONETICS CORP
Txns: Sold 2,391 shares @ $90, valued at $215.2k
Exercised 2,391 options to buy @ $56.57, valued at $135.3k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy